Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/69913
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hemsley, K. | - |
dc.contributor.author | Hopwood, J. | - |
dc.date.issued | 2011 | - |
dc.identifier.citation | Journal of Inherited Metabolic Disease, 2011; 34(5):1003-1012 | - |
dc.identifier.issn | 0141-8955 | - |
dc.identifier.issn | 1573-2665 | - |
dc.identifier.uri | http://hdl.handle.net/2440/69913 | - |
dc.description.abstract | Lysosomal storage disorders are inherited metabolic diseases in which a mutation in a gene encoding a lysosomal enzyme or lysosome-related protein results in the intra-cellular accumulation of substrate and reduced cell/tissue function. Few patients with neurodegenerative lysosomal storage disorders have access to safe and effective treatments although many therapeutic strategies have been or are presently being studied in vivo thanks to the availability of a large number of animal models. This review will describe the comparative advancement of a variety of therapeutic strategies through the 'research pipeline'. Our goal is to provide information for clinicians, researchers and patients/families alike on the leading therapeutic candidates at this point in time, and also to provide information on emerging approaches that may provide a safe and effective treatment in the future. The length of the pipeline represents the significant and sustained effort required to move a novel concept from the laboratory into the clinic. | - |
dc.description.statementofresponsibility | Kim M. Hemsley, John J. Hopwood | - |
dc.language.iso | en | - |
dc.publisher | Kluwer Academic Publ | - |
dc.rights | © SSIEM and Springer 2011 | - |
dc.source.uri | http://dx.doi.org/10.1007/s10545-011-9341-5 | - |
dc.subject | Animals | - |
dc.subject | Humans | - |
dc.subject | Lysosomal Storage Diseases, Nervous System | - |
dc.subject | Neurodegenerative Diseases | - |
dc.subject | Therapies, Investigational | - |
dc.subject | Cell Transplantation | - |
dc.subject | Concept Formation | - |
dc.subject | Models, Biological | - |
dc.subject | Evidence-Based Practice | - |
dc.subject | Enzyme Replacement Therapy | - |
dc.subject | Genetic Therapy | - |
dc.title | Emerging therapies for neurodegenerative lysosomal storage disorders - from concept to reality | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1007/s10545-011-9341-5 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Hemsley, K. [0000-0003-1038-9884] | - |
Appears in Collections: | Aurora harvest 5 Paediatrics publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.